Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Eikon Therapeutics revenue
Eikon Therapeutics's revenue is $8.5 million.
What is Eikon Therapeutics's revenue?
- Eikon Therapeutics has 175 employees, and the revenue per employee ratio is $48,571.
- Eikon Therapeutics peak revenue was $8.5M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Eikon Therapeutics financing
Eikon Therapeutics received early financing of $148.0M on 2021-05-05.
| Series | Round size | Date |
|---|---|---|
| Series A | $148M | 05/2021 |
| Series B | $518M | 01/2022 |
Eikon Therapeutics investors
| Investors | Security type |
|---|---|
| Lux Capital | Series A |
| Foresite Capital | Series A |
| The Column Group | Series A |
| Innovation Endeavors | Series A |
| EcoR1 Capital, LLC | Series B |
| Hartford HealthCare Endowment | Series B |
| HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD | Series B |
| Soros Capital Management | Series B |
| Lux Capital | Series B |
| The Column Group | Series B |
| Innovation Endeavors | Series B |
| STEPSTONE GROUP INC. | Series B |
| Khaira Capital | Series B |
| Schroders Capital | Series B |
| General Catalyst | Series B |
| UC Investments | Series B |
| AME Cloud Ventures | Series B |
| E15 VC | Series B |
| Canada Pension Plan Investment Board (CPPIB) | Series B |
| Foresite Capital | Series B |
| T. Rowe Price Group, Inc. | Series B |
| Abu Dhabi Investment Authority (Adia) | Series B |
| Horizons Ventures | Series B |
Search for jobs
Eikon Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Eikon Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Eikon Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Eikon Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Eikon Therapeutics. The data presented on this page does not represent the view of Eikon Therapeutics and its employees or that of Zippia.
Eikon Therapeutics may also be known as or be related to Eikon Therapeutics and Eikon Therapeutics, Inc.